Manufacturing Establishments (2)
Aurobindo Pharma Limited
650844777
Aurobindo Pharma Limited
918917642
Products (4)
Carvedilol
65862-143
ANDA078332
ANDA (C73584)
ORAL
August 23, 2023
Carvedilol
65862-145
ANDA078332
ANDA (C73584)
ORAL
August 23, 2023
Carvedilol
65862-144
ANDA078332
ANDA (C73584)
ORAL
August 23, 2023
Carvedilol
65862-142
ANDA078332
ANDA (C73584)
ORAL
August 23, 2023
Drug Labeling Information
Indications & Usage Section
Highlight: Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of:
- mild to severe chronic heart failure (1.1)
- left ventricular dysfunction following myocardial infarction in clinically stable patients (1.2)
- hypertension (1.3)
1 INDICATIONS AND USAGE
1.1 Heart Failure
Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7.4), Clinical Studies (14.1)].
1.2 Left Ventricular Dysfunction following Myocardial Infarction
Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies (14.2)].
1.3 Hypertension
Carvedilol tablets are indicated for the management of essential hypertension [see Clinical Studies (14.3, 14.4)]. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see Drug Interactions (7.2)].